These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8784572

  • 1. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.
    Ishida S, Feng N, Tang B, Gilbert JM, Greenberg HB.
    J Clin Microbiol; 1996 Jul; 34(7):1694-700. PubMed ID: 8784572
    [Abstract] [Full Text] [Related]

  • 2. Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice.
    Ishida SI, Feng N, Gilbert JM, Tang B, Greenberg HB.
    J Infect Dis; 1997 Jun; 175(6):1317-23. PubMed ID: 9180169
    [Abstract] [Full Text] [Related]

  • 3. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH, Basu M, Rae MN, McNeal MM, Ward RL.
    Virology; 1998 Oct 10; 250(1):230-40. PubMed ID: 9770437
    [Abstract] [Full Text] [Related]

  • 4. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice.
    Dharakul T, Labbe M, Cohen J, Bellamy AR, Street JE, Mackow ER, Fiore L, Rott L, Greenberg HB.
    J Virol; 1991 Nov 10; 65(11):5928-32. PubMed ID: 1656079
    [Abstract] [Full Text] [Related]

  • 5. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique.
    Richardson SC, Grimwood K, Bishop RF.
    J Clin Microbiol; 1993 Feb 10; 31(2):377-85. PubMed ID: 8381813
    [Abstract] [Full Text] [Related]

  • 6. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection.
    Colomina J, Gil MT, Codoñer P, Buesa J.
    J Med Virol; 1998 Sep 10; 56(1):58-65. PubMed ID: 9700634
    [Abstract] [Full Text] [Related]

  • 7. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M, Cai L.
    Viral Immunol; 2001 Sep 10; 14(1):31-47. PubMed ID: 11270595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.
    Johansen K, Svensson L.
    Arch Virol; 1997 Sep 10; 142(7):1491-8. PubMed ID: 9267458
    [Abstract] [Full Text] [Related]

  • 10. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus.
    Fiore L, Dunn SJ, Ridolfi B, Ruggeri FM, Mackow ER, Greenberg HB.
    J Gen Virol; 1995 Aug 10; 76 ( Pt 8)():1981-8. PubMed ID: 7636478
    [Abstract] [Full Text] [Related]

  • 11. Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.
    Gorrell RJ, Bishop RF.
    Clin Diagn Lab Immunol; 1997 Sep 10; 4(5):509-14. PubMed ID: 9302196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S, Pastor AR, Tamminen K, López-Guerrero V, Esquivel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V.
    Hum Vaccin Immunother; 2014 Sep 10; 10(7):2039-47. PubMed ID: 25424814
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
    Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB.
    Science; 1996 Apr 05; 272(5258):104-7. PubMed ID: 8600516
    [Abstract] [Full Text] [Related]

  • 15. Protection against rotavirus infections by DNA vaccination.
    Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Wang S, Robinson HL.
    J Infect Dis; 1996 Sep 05; 174 Suppl 1():S93-7. PubMed ID: 8752297
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination.
    Taniguchi K, Urasawa T, Kobayashi N, Ahmed MU, Adachi N, Chiba S, Urasawa S.
    J Clin Microbiol; 1991 Mar 05; 29(3):483-7. PubMed ID: 1709946
    [Abstract] [Full Text] [Related]

  • 18. Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.
    Menchaca G, Padilla-Noriega L, Méndez-Toss M, Contreras JF, Puerto FI, Guiscafré H, Mota F, Herrera I, Cedillo R, Muñoz O, Ward R, Hoshino Y, López S, Arias CF.
    Clin Diagn Lab Immunol; 1998 May 05; 5(3):328-34. PubMed ID: 9605987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.